These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33014154)

  • 21. Ubiquitin-conjugating enzyme E2T (UBE2T) and denticleless protein homolog (DTL) are linked to poor outcome in breast and lung cancers.
    Perez-Peña J; Corrales-Sánchez V; Amir E; Pandiella A; Ocana A
    Sci Rep; 2017 Dec; 7(1):17530. PubMed ID: 29235520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer.
    Ren H; Chen Z; Yang L; Xiong W; Yang H; Xu K; Zhai E; Ding L; He Y; Song X
    Cancer Manag Res; 2019; 11():4917-4930. PubMed ID: 31213910
    [No Abstract]   [Full Text] [Related]  

  • 23. Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinoma.
    Liu F; Zhu C; Gao P; Zheng S; Li C
    Anticancer Drugs; 2020 Sep; 31(8):836-846. PubMed ID: 32796405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of AMPD2 and obesity are associated with poor prognosis in colorectal cancer.
    Wang F; Liu Y; Jiang J; Qin Y; Ge X; Li J; Qi X; Mao Y
    Int J Clin Exp Pathol; 2018; 11(1):216-223. PubMed ID: 31938103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of UBE2T predicts poor prognosis and survival in multiple myeloma.
    Zhang W; Zhang Y; Yang Z; Liu X; Yang P; Wang J; Hu K; He X; Zhang X; Jing H
    Cancer Gene Ther; 2019 Nov; 26(11-12):347-355. PubMed ID: 30622320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer.
    Wen M; Kwon Y; Wang Y; Mao JH; Wei G
    Oncotarget; 2015 Sep; 6(28):25226-39. PubMed ID: 26308072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.
    Zhang Y; Zhang Y; Wang J; Yang J; Yang G
    Oncol Lett; 2020 May; 19(5):3567-3577. PubMed ID: 32269631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TNNT2 as a potential biomarker for the progression and prognosis of colorectal cancer.
    Jing L; Feng L; Zhou Z; Shi S; Deng R; Wang Z; Zhang Y; Ren Z; Liu Y
    Oncol Rep; 2020 Aug; 44(2):628-636. PubMed ID: 32627044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diagnostic and prognostic value of UBE2T in intrahepatic cholangiocarcinoma.
    Yu H; Wang H; Dong W; Cao ZY; Li R; Yang C; Cong WM; Dong H; Jin GZ
    PeerJ; 2020; 8():e8454. PubMed ID: 32025379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ring finger protein 215 is a potential prognostic biomarker involved in immune infiltration and angiogenesis in colorectal cancer.
    Wu JB; Li XJ; Liu H; Liu XP
    Biomed Rep; 2023 Jul; 19(1):50. PubMed ID: 37383678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UBE2T promotes glioblastoma malignancy through ubiquitination-mediated degradation of RPL6.
    Tao X; Wu X; Zhou P; Yu X; Zhao C; Peng X; Zhang K; Shen L; Peng J; Yang L
    Cancer Sci; 2023 Feb; 114(2):521-532. PubMed ID: 36156329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NEDD4L-induced ubiquitination mediating UBE2T degradation inhibits progression of lung adenocarcinoma via PI3K-AKT signaling.
    Chen Y; Hong H; Wang Q; Li J; Zhang W; Chen T; Li P
    Cancer Cell Int; 2021 Nov; 21(1):631. PubMed ID: 34838005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study.
    Huang F; Peng Y; Ye Q; Chen J; Li Y; Liu S; Xu Y; Huang L
    World J Surg Oncol; 2020 Oct; 18(1):274. PubMed ID: 33099318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UBE2T promotes breast cancer tumor growth by suppressing DNA replication stress.
    Dutta R; Guruvaiah P; Reddi KK; Bugide S; Reddy Bandi DS; Edwards YJK; Singh K; Gupta R
    NAR Cancer; 2022 Dec; 4(4):zcac035. PubMed ID: 36338541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer.
    Huang X; Yang Y; Yang C; Li H; Cheng H; Zheng Y
    Oncol Lett; 2020 Jun; 19(6):3751-3760. PubMed ID: 32382328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of SKA3 correlates with poor prognosis in female early breast cancer.
    Zhong Y; Zhuang Z; Mo P; Lin M; Gong J; Huang J; Mo H; Lu Y; Huang M
    PeerJ; 2021; 9():e12506. PubMed ID: 34993016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinoma.
    Liu LL; Zhu JM; Yu XN; Zhu HR; Shi X; Bilegsaikhan E; Guo HY; Wu J; Shen XZ
    Cancer Manag Res; 2019; 11():8359-8370. PubMed ID: 31571992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting UBE2T Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Regulating Pyrimidine Metabolism and Replication Stress.
    Jiang X; Ma Y; Wang T; Zhou H; Wang K; Shi W; Qin L; Guan J; Li L; Long B; Wang J; Guan X; Ye H; Yang J; Yu Z; Jiao Z
    Gastroenterology; 2023 Jun; 164(7):1232-1247. PubMed ID: 36842710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
    Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
    J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.